Christopher M Dwyer (Chris Dwyer)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Dna Methylation

Editorial Comment

Top Venues

Neurology(R) neuroimmunology & neuroinflammation

European journal of neurology

Therapeutic advances in neurological disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher M Dwyer, Sifat Sharmin, Tomas Kalincik
Rates of John Cunningham virus seroconversion greatly reduced in natalizumab-treated patients during COVID-19-related lockdowns. European journal of neurology (2023)
Michele D Binder, Eze C Nwoke, Ellen Morwitch, Christopher M Dwyer, Vivien Li, Alexandre Xavier, Rodney A Lea, Jeannette Lechner-Scott, Bruce V Taylor, Anne-Louise Ponsonby, Trevor J Kilpatrick, null null
HLA-DRB1*15:01 and the MERTK Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MS. Neurology(R) neuroimmunology & neuroinflammation 11 (2) (2023)
Michele D Binder, Eze C Nwoke, Ellen Morwitch, Christopher M Dwyer, Vivien Li, Alexandre Xavier, Rodney A Lea, Jeannette Lechner-Scott, Bruce V Taylor, Anne-Louise Ponsonby, Trevor J Kilpatrick, null null
HLA-DRB1*15:01 and the MERTK Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MS. Neurology(R) neuroimmunology & neuroinflammation 11 (2) (2023)
Christopher M Dwyer, Vilija G Jokubaitis, Jim Stankovich, Josephine Baker, Jodi Haartsen, Helmut Butzkueven, Adriana Cartwright, Neil Shuey, Yara Dadalti Fragoso, Louise Rath, Olga Skibina, Kylie Fryer, Ernest Butler, Jennifer Coleman, Jennifer MacIntrye, Richard Macdonell, Anneke Van Der Walt
High rates of JCV seroconversion in a large international cohort of natalizumab-treated patients. Therapeutic advances in neurological disorders 14 (2021)